AMF

Kaufman & Broad SA: AVAILABILITY OF THE 2023 UNIVERSAL REGISTRATION DOCUMENT

Retrieved on: 
Wednesday, April 10, 2024
AMF, KB Home, Audit

Kaufman & Broad, a French national real estate developer, filled its 2023 Universal Registration Document, with the Autorité des Marchés Financiers (AMF) on March 28, 2024.

Key Points: 
  • Kaufman & Broad, a French national real estate developer, filled its 2023 Universal Registration Document, with the Autorité des Marchés Financiers (AMF) on March 28, 2024.
  • The Universal Registration Document is available free of charge and upon request at the office of Kaufman & Broad SA (17, quai Président Paul Doumer 92400 Courbevoie France) and on the websites of the Company ( www.kaufmanbroad.fr ) and the AMF ( www.amf-france.org ).
  • The Universal Registration Document includes in particular:
    The Board of Directors management report of the Company;
    The Board of Directors report on the Company’s Corporate Governance;
    The fees of the statutory auditors.

Waga Energy increases the amount allocated to liquidity contract

Retrieved on: 
Wednesday, April 10, 2024
AMF, EPA, Portzamparc, Cryptocurrency

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • On April 2, 2024, Waga Energy (EPA: WAGA) signed an amendment to the liquidity contract concluded with Portzamparc-BNP Paribas on November 19, 2021 in order to allocate an additional €300,000 to the contract.
  • This arrangement, which falls within the framework of AMF decision 2021-01 of June 22, 2021 on the establishment of liquidity contracts on equity securities consistent with accepted market practice, is intended to improve share liquidity and trading conditions for investors.
  • As such, the liquidity contract position after allocation of these new funds as of April 2, 2024 is:

Waga Energy announces the launch of an accelerated bookbuild offering for a minimum amount of €45 million

Retrieved on: 
Wednesday, April 10, 2024
EGM, Natural gas, Growth, Offering, CMA-CGM, Lazard, Partnership, Financial adviser, Sale, IPO, Risk, EPA, Investment, AMF, Calendar, Legal Advisor, Renewable natural gas, Commercial code, RNG, Security (finance)

We now own 20 units in operation, 13 under construction, and with approximately 160 projects in the pipeline.

Key Points: 
  • We now own 20 units in operation, 13 under construction, and with approximately 160 projects in the pipeline.
  • Half of these projects are located in the United States, where we have recently commenced operations at our first facility.
  • This financing will enable us to capitalize on opportunities in this strategic market, where we have won several RFPs in recent months.
  • Waga Energy intends to raise gross proceeds amounting to a minimum of €45 million from the Offering of which €18.3 million have already been committed through the Subscription Commitments.

EQS-News: Abivax publishes financial reports with the French and U.S. securities regulatory agencies

Retrieved on: 
Wednesday, April 10, 2024
EST, Q&A, Patient, Webcast, Document, Annual report, Euronext Paris, AMF, Therapy, Cryptocurrency

Abivax publishes financial reports with the French and U.S. securities regulatory agencies

Key Points: 
  • Abivax publishes financial reports with the French and U.S. securities regulatory agencies
    The issuer is solely responsible for the content of this announcement.
  • The Universal Registration Document includes the 2023 annual financial report, the management report including the report on corporate governance, as well as the reports of the statutory auditors.
  • The Abivax management will give an overview of the Company’s 2023 highlights and projects going forward, followed by a live Q&A session.
  • To participate and ask questions during the webcast, please register via the Abivax website .

Abivax publishes financial reports with the French and U.S. securities regulatory agencies

Retrieved on: 
Friday, April 5, 2024
EST, Q&A, Patient, Webcast, Document, Annual report, Euronext Paris, AMF, Therapy

The Universal Registration Document includes the 2023 annual financial report, the management report including the report on corporate governance, as well as the reports of the statutory auditors.

Key Points: 
  • The Universal Registration Document includes the 2023 annual financial report, the management report including the report on corporate governance, as well as the reports of the statutory auditors.
  • A webcast will be organized on Monday, April 8, 2024, at 2:30 p.m. CEST (8:30 a.m. EST) following the announcement of the 2023 yearly results.
  • The Abivax management will give an overview of the Company’s 2023 highlights and projects going forward, followed by a live Q&A session.
  • To participate and ask questions during the webcast, please register via the Abivax website .

GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F

Retrieved on: 
Friday, April 5, 2024
Statute, Patient, Bank statement, Annual report, AMF, Audit

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 5, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the filing of its 2023 Universal Registration Document with the Autorité des marchés financiers (AMF ; filing n° D.24-0246) and its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission (SEC).

Key Points: 
  • Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 5, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the filing of its 2023 Universal Registration Document with the Autorité des marchés financiers (AMF ; filing n° D.24-0246) and its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission (SEC).
  • These annual reports are available to the public free of charge in accordance with applicable regulations and may be viewed at and downloaded from GENFIT’s website at ir.genfit.com .
  • The 2023 Registration Document will also be available shortly on the AMF’s website: www.amf-france.org and the Annual Report on Form 20-F is available on the website of the SEC ( www.sec.gov ).
  • GENFIT’s 2023 Universal Registration Document includes, in particular:
    the Board of Directors’ report on corporate governance,
    the Statutory Auditors’ reports on the annual and consolidated financial statements and related-party agreements, and
    the table summarizing the fees paid to the Statutory Auditors.

Cegedim: Release of its 2023 Universal Registration Document

Retrieved on: 
Thursday, April 4, 2024
AMF, Share repurchase, Risk management, Audit

Cegedim , an innovative technology and services company, announces that its 2023 Universal Registration Document (in French) has been published in compliance with Autorité des Marchés Financiers (AMF) regulations on April 3, 2024, under the number: D.24-0233.

Key Points: 
  • Cegedim , an innovative technology and services company, announces that its 2023 Universal Registration Document (in French) has been published in compliance with Autorité des Marchés Financiers (AMF) regulations on April 3, 2024, under the number: D.24-0233.
  • The report is available free of charge:
    The English version will be uploaded in the next few days.
  • The 2023 Universal Registration Document includes notably:
    - The 2023 consolidated financial statements of the Group;
    ‐ The 2023 statutory financial statements of Cegedim S.A.;
    ‐ The related auditors’ reports on the consolidated and the statutory financial statements;
    ‐ The 2023 management report including notably social, societal and environmental information;
    ‐ The Board of Directors’ report on corporate governance;
    ‐ Information regarding internal control and risk management;
    ‐ The draft resolutions submitted to the Shareholders’ Meeting of 14 June 2024;
    ‐ Information concerning fees paid to the Statutory Auditors; and
    ‐ Information on the share buyback programme.

Inventiva announces filing of its 2023 Universal Registration Document and 2023 Annual Report on Form 20-F

Retrieved on: 
Wednesday, April 3, 2024
Euronext Paris, AMF, Fatty liver disease, Annual report

Daix (France), Long Island City (New York, United States), April 3, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), also known as non-alcoholic steatohepatitis (“NASH”), and other diseases with significant unmet medical needs, today announced that it had filed its 2023 Universal Registration Document for the year ended December 31, 2023, including the management report and the annual financial report, with the French “Autorité des Marchés Financiers” (“AMF”) and its 2023 Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission (“SEC”).

Key Points: 
  • Daix (France), Long Island City (New York, United States), April 3, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), also known as non-alcoholic steatohepatitis (“NASH”), and other diseases with significant unmet medical needs, today announced that it had filed its 2023 Universal Registration Document for the year ended December 31, 2023, including the management report and the annual financial report, with the French “Autorité des Marchés Financiers” (“AMF”) and its 2023 Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission (“SEC”).
  • These documents can be accessed on the “Investors” section of the Company’s corporate website ( www.inventivapharma.com ).
  • In addition, the 2023 Universal Registration Document is available on the website of the AMF ( www.amf-france.org ) and the 2023 Annual Report on Form 20-F is also available on the website of

Sword Group: H2 2023 Report of the Liquidity Agreement

Retrieved on: 
Thursday, March 28, 2024
AMF, ODDO BHF, Sale

Under the liquidity contract awarded by Sword Group to ODDO BHF, as of 31/12/2023, the following resources appeared on the account of liquidity:

Key Points: 
  • Under the liquidity contract awarded by Sword Group to ODDO BHF, as of 31/12/2023, the following resources appeared on the account of liquidity:
    - Number of transactions executed during the semester at purchase: 1,116
    - Number of transactions executed during the semester on sale: 1,080
    - Volume exchanged over the semester upon purchase: 34,943 shares for an amount of €1,319,183
    - Volume exchanged over the semester for sale: 38,733 shares for an amount of €1,455,889
    As a reminder, during the last balance sheet of 30/06/2023, the following resources appeared in the liquidity account:
    The implementation of the liquidity contract is carried out in accordance with AMF Decision No.
  • 2018-01 dated July 2, 2018, establishing liquidity contracts on equity securities as accepted market practice.

10 Barrel Brewing Unveils Newest Ready-to-Drink Canned Cocktails

Retrieved on: 
Tuesday, March 26, 2024
AMF, Innovation, RTD, Ice, Lemonade, TSX, Taste, TLRY, Liquor

BEND, Ore., March 26, 2024 (GLOBE NEWSWIRE) -- 10 Barrel Brewing Co. (“10 Barrel”), an award-winning pioneer in the craft brewing industry and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is thrilled to introduce its latest innovations in the world of ready-to-drink canned cocktails: Disco Lemonade and AMF.

Key Points: 
  • BEND, Ore., March 26, 2024 (GLOBE NEWSWIRE) -- 10 Barrel Brewing Co. (“10 Barrel”), an award-winning pioneer in the craft brewing industry and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is thrilled to introduce its latest innovations in the world of ready-to-drink canned cocktails: Disco Lemonade and AMF.
  • Disco Lemonade and AMF embody 10 Barrel's commitment to crafting premium beverages that capture the essence of the party scene.
  • “With cocktails as funky as Disco Lemonade and AMF, we had an obligation to craft a beverage that can turn any occasion up to 11,” says Ben Shirley, Innovation Manager at 10 Barrel Brewing.
  • Whether sipped over ice or enjoyed straight from the can, these cocktails elevate any occasion to new heights of revelry and excitement.